Conditioned media from human adipose tissue-derived mesenchymal stem cells and umbilical cord-derived mesenchymal stem cells efficiently induced the apoptosis and differentiation in human glioma cell lines in vitro

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Yang, Chao ^a   Lei, Deqiang ^a   Ouyang, Weixiang ^a   Ren, Jinghua ^a   Li, Huiyu ^a   Hu, Jingqiong ^a   Huang, Shiang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIM PROTEIN; CASPASE 3; CASPASE 8; CASPASE 9; ENDOGLIN; F ACTIN; HERMES ANTIGEN; LYMPHOTOXIN; MICROSOMAL AMINOPEPTIDASE; PROTEIN BCL 2; PROTEIN BCL W; PROTEIN BID; PROTEIN P21; PROTEIN P27; PROTEIN P53; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SURVIVIN; THY 1 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; X LINKED INHIBITOR OF APOPTOSIS; CONDITIONED MEDIUM;

ADIPOSE TISSUE DERIVED MESENCHYMAL STEM CELL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CULTURE; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; GLIOMA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYMAL STEM CELL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; REAL TIME POLYMERASE CHAIN REACTION; UMBILICAL CORD DERIVED MESENCHYMAL STEM CELL; UPREGULATION; ADIPOSE TISSUE; CONDITIONED MEDIUM; CYTOLOGY; DRUG EFFECTS; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE; UMBILICAL CORD;

ADIPOSE TISSUE; APOPTOSIS; CASPASE 3; CASPASE 9; CELL DIFFERENTIATION; CELL LINE, TUMOR; CULTURE MEDIA, CONDITIONED; HUMANS; MESENCHYMAL STROMAL CELLS; UMBILICAL CORD;

EID: 84902126135     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/109389     Document Type: Article

References (40)

1. Wang Y., Jiang T., Understanding high grade glioma: molecular mechanism, therapy and comprehensive management. Cancer Letters 2013 331 2 139 146
2. Bexell D., Svensson A., Bengzon J., Stem cell-based therapy for malignant glioma. Cancer Treatment Reviews 2013 39 4 358 365
3. Rahman M., Hoh B., Kohler N., Dunbar E. M., Murad G. J., The future of glioma treatment: stem cells, nanotechnology and personalized medicine. Future Oncology 2012 8 9 1149 1156
4. Sai K., Yang Q. Y., Shen D., Chen Z. P., Chemotherapy for gliomas in mainland China: an overview. Oncology Letters 2013 5 5 1448 1452
5. Szczepanek D., Marchel A., Moskała M., Krupa M., Kunert P., Trojanowski T., Efficacy of concomitant and adjuvant temozolomide in glioblastoma treatment. A multicentre randomized study. Neurologia i Neurochirurgia Polska 2013 47 2 101 108
6. Strik H. M., Marosi C., Kaina B., Neyns B., Temozolomide dosing regimens for glioma patients. Current Neurology and Neuroscience Reports 2012 12 3 286 293
7. Scaringi C., Enrici R. M., Minniti G., Combining molecular targeted agents with radiation therapy for malignant gliomas. Journal of OncoTargets and Therapy 2013 6 1079 1095
8. Mok P. L., Leong C. F., Cheong S. K., Cellular mechanisms of emerging applications of mesenchymal stem cells. The Malaysian Journal of Pathology 2013 35 1 17 32
9. Neirinckx V., Coste C., Rogister B., Wislet-Gendebien S., Concise review: adult mesenchymal stem cells, adult neural crest stem cells, and therapy of neurological pathologies: a state of play. Stem Cells Translational Medicine 2013 2 4 284 296 10.5966/sctm.2012-0147
10. Bak X. Y., Lam D. H., Yang J., Ye K., Wei E. L. X., Lim S. K., Wang S., Human embryonic stem cell-derived mesenchymal stem cells as cellular delivery vehicles for prodrug gene therapy of glioblastoma. Human Gene Therapy 2011 22 11 1365 1377 2-s2.0-80053456301 10.1089/hum.2010.212
11. Kim S. M., Kim D.-S., Jeong C. H., Kim D. H., Kim J. H., Jeon H. B., Kwon S.-J., Jeun S.-S., Yang Y. S., Oh W., Chang J. W., CXC chemokine receptor 1 enhances the ability of human umbilical cord blood-derived mesenchymal stem cells to migrate toward gliomas. Biochemical and Biophysical Research Communications 2011 407 4 741 746 2-s2.0-79954997170 10.1016/j.bbrc.2011.03.093
12. Jiao H., Guan F., Yang B., Li J., Shan H., Song L., Hu X., Du Y., Human umbilical cord blood-derived mesenchymal stem cells inhibit C6 glioma via downregulation of cyclin D1. Neurology India 2011 59 2 241 247 2-s2.0-79955409834 10.4103/0028-3886.79134
13. Choi S. A., Lee J. Y., Wang K.-C., Phi J. H., Song S. H., Song J., Kim S.-K., Human adipose tissue-derived mesenchymal stem cells: characteristics and therapeutic potential as cellular vehicles for prodrug gene therapy against brainstem gliomas. European Journal of Cancer 2012 48 1 129 137 2-s2.0-80053536433 10.1016/j.ejca.2011.04.033
14. Doucette T., Rao G., Yang Y., Gumin J., Shinojima N., Nebiyou Bekele B., Qiao W., Zhang W., Lang F. F., Mesenchymal stem cells display tumor-specific tropism in an RCAS/Ntv-a glioma model. Neoplasia 2011 13 8 716 725 2-s2.0-80051516653 10.1593/neo.101680
15. Yin J., Kim J.-K., Moon J.-H., Beck S., Piao D., Jin X., Kim S.-H., Lim Y. C., Nam D.-H., You S., Kim H., Choi Y.-J., HMSC-mediated concurrent delivery of endostatin and carboxylesterase to mouse xenografts suppresses glioma initiation and recurrence. Molecular Therapy 2011 19 6 1161 1169 2-s2.0-79957897226 10.1038/mt.2011.28
16. Park S. A., Ryu C. H., Kim S. M., Lim J. Y., Park S. I., Jeong C. H., Jun J. A., Oh J. H., Park S. H., Oh W., Jeun S.-S., CXCR4-transfected human umbilical cord blood-derived mesenchymal stem cells exhibit enhanced migratory capacity toward gliomas. International Journal of Oncology 2011 38 1 97 103 2-s2.0-78650836835 10.3892/ijo-00000828
17. Choi S. A., Hwang S.-K., Wang K.-C., Cho B.-K., Phi J. H., Lee J. Y., Jung H. W., Lee D.-H., Kim S.-K., Therapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma. Neuro-Oncology 2011 13 1 61 69 2-s2.0-79951602634 10.1093/neuonc/noq147
18. Ho I. A., Toh H. C., Ng W. H., Teo Y. L., Guo C. M., Hui K. M., Lam P. Y., Human bone marrow-derived mesenchymal stem cells suppress human glioma growth through inhibition of angiogenesis. Stem Cells 2013 31 1 146 155
19. Hu L., Hu J., Zhao J., Liu J., Ouyang W., Yang C., Gong N., Du L., Khanal A., Chen L., Side-by-side comparison of the biological characteristics of human umbilical cord and adipose tissue-derived mesenchymal stem cells. BioMed Research International 2013 2013 12 438243 10.1155/2013/438243
20. Griguer C. E., Oliva C. R., Bioenergetics pathways and therapeutic resistance in gliomas: emerging role of mitochondria. Current Pharmaceutical Design 2011 17 23 2421 2427 2-s2.0-80053487181 10.2174/138161211797249251
21. Gutiérrez-Fernández M., Rodríguez-Frutos B., Otero-Ortega L., Ramos-Cejudo J., Fuentes B., Díez-Tejedor E., Adipose tissue-derived stem cells in stroke treatment: from bench to bedside. Discovery Medicine 2013 16 86 37 43
22. Xu F., Shi J., Yu B., Ni W., Wu X., Gu Z., Chemokines mediate mesenchymal stem cell migration toward gliomas in vitro. Oncology Reports 2010 23 6 1561 1567 2-s2.0-77951753751 10.3892/or-00000796
23. Kim D.-S., Kim J. H., Kwon Lee J., Choi S. J., Kim J.-S., Jeun S.-S., Oh W., Yang Y. S., Chang J. W., Overexpression of CXC chemokine receptors is required for the superior glioma-tracking property of umbilical cord blood-derived mesenchymal stem cells. Stem Cells and Development 2009 18 3 511 519 2-s2.0-65349149983 10.1089/scd.2008.0050
24. Bexell D., Gunnarsson S., Tormin A., Darabi A., Gisselsson D., Roybon L., Scheding S., Bengzon J., Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas. Molecular Therapy 2009 17 1 183 190 2-s2.0-58149235124 10.1038/mt.2008.229
25. Kim S. M., Woo J. S., Jeong C. H., Ryu C. H., Jang J. D., Jeun S. S., Potential application of temozolomide in mesenchymal stem cell-Based TRAIL gene therapy against malignant glioma. Stem Cells Translational Medicine 2014 3 2 172 182
26. Fei S., Qi X., Kedong S., Guangchun J., Jian L., Wei Q., The antitumor effect of mesenchymal stem cells transduced with a lentiviral vector expressing cytosine deaminase in a rat glioma model. Journal of Cancer Research and Clinical Oncology 2012 138 2 347 357 2-s2.0-84857055800 10.1007/s00432-011-1104- z
27. Kosaka H., Ichikawa T., Kurozumi K., Kambara H., Inoue S., Maruo T., Nakamura K., Hamada H., Date I., Therapeutic effect of suicide gene-transferred mesenchymal stem cells in a rat model of glioma. Cancer Gene Therapy 2012 19 8 572 578
28. Akimoto K., Kimura K., Nagano M., Takano S., To'a Salazar G., Yamashita T., Ohneda O., Umbilical cord blood-derived mesenchymal stem cells inhibit, but adipose tissue-derived mesenchymal stem cells promote, glioblastoma multiforme proliferation. Stem Cells and Development 2013 22 9 1370 1386
29. Behnan J., Isakson P., Joel M., Cilio C., Langmoen I. A., Vik-Mo E. O., Badn W., Recruited brain tumor-derived mesenchymal stem cells contribute to brain tumor progression. Stem Cells 2013 32 5 1110 123 10.1002/stem.1614
30. Stegh A. H., DePinho R. A., Beyond effector caspase inhibition: Bcl2L12 neutralizes p53 signaling in glioblastoma. Cell Cycle 2011 10 1 33 38 2-s2.0-78650831721 10.4161/cc.10.1.14365
31. Ordys B. B., Launay S., Deighton R. F., McCulloch J., Whittle I. R., The role of mitochondria in glioma pathophysiology. Molecular Neurobiology 2010 42 1 64 75 2-s2.0-77954218340 10.1007/s12035-010-8133-5
32. Kögel D., Fulda S., Mittelbronn M., Therapeutic exploitation of apoptosis and autophagy for glioblastoma. Anti-Cancer Agents in Medicinal Chemistry 2010 10 6 438 449 2-s2.0-78649805568
33. Alexander B. M., Pinnell N., Wen P. Y., D'Andrea A., Targeting DNA repair and the cell cycle in glioblastoma. Journal of Neuro-Oncology 2012 107 3 463 477
34. Ku M. C., Wolf S. A., Respondek D., Matyash V., Pohlmann A., Waiczies S., Waiczies H., Niendorf T., Synowitz M., Glass R., Kettenmann H., GDNF mediates glioblastoma-induced microglia attraction but not astrogliosis. Acta Neuropathologica 2013 125 4 609 620
35. Balik V., Mirossay P., Bohus P., Sulla I., Mirossay L., Sarissky M., Flow cytometry analysis of neural differentiation markers expression in human glioblastomas may predict their response to chemotherapy. Cellular and Molecular Neurobiology 2009 29 6-7 845 858 2-s2.0-68149167764 10.1007/s10571-009-9366-6
36. 3)-induced differentiation of acute promyelocytic leukemia cell line. Leukemia Research 2010 34 11 1501 1505 2-s2.0-77957018264 10.1016/j.leukres. 2010.02.016
37. 3: a model of molecular target-based cancer therapy. Cancer Biology and Therapy 2002 1 6 614 620 2-s2.0-0037974596
38. 3 phenylbutyrate, and G-CSF in acute promyelocytic leukemia. Haematologica 2007 92 12 1615 1622 2-s2.0-37049011854 10.3324/haematol.10607 (Pubitemid 350248240)
39. 3 in glioma cell lines. Canadian Journal of Neurological Sciences 2010 37 4 504 511 2-s2.0-77953350363
40. He S., Zhu W., Zhou Y., Huang Y., Ou Y., Li Y., Yan G., Transcriptional and post-transcriptional down-regulation of cyclin D1 contributes to C6 glioma cell differentiation induced by forskolin. Journal of Cellular Biochemistry 2011 112 9 2241 2249 2-s2.0-84860389987 10.1002/jcb.23140